Mentoring Gender, Selecting Sex
By Osagie Obasogie,
Boston Globe
| 08. 08. 2005
It's a boy! It's a girl! Until the 1970s, these words welcomed virtually every child into the world. In less than one generation, however, new reproductive technologies have shifted this announcement from the delivery room to the obstetricians' office; ultrasounds and amniocenteses now allow expecting parents to choose their nursery walls' paint color months before giving birth.
The science and business of sex identification took yet another quantum leap forward this past week with the Pregnancystore.com's release of the Baby Gender Mentor Home DNA Gender Testing Kit. Now, a woman can know her child's sex shortly after she discovers her pregnancy. As soon as five weeks after conception, she can prick her finger, FedEx a blood sample to Acu-Gen Biolab in Lowell, MA, and have the sex of her sprouting embryo emailed to her faster than Netflix can send her next movie.
An unequivocal good, many say. What's more harmless than learning whether to buy dolls or trucks for the toy chest?
Ultrasounds and amniocenteses cannot accurately determine a fetus' sex until at least four months into pregnancy and sometimes...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...